MetaCap

BillionToOne Financial Statements

NASDAQ: BLLNHealth CareMedical SpecialitiesUSD

98.09+2.68 (+2.81%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

BillionToOne revenue and earnings

In fiscal 2025, BillionToOne generated $305.1 million in revenue, up 100.0% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $7.5 million, for a net margin of 2.4% versus a median of -71.3% in the prior 2 years. Gross margin was 68.3% (up from 53.0%) and operating margin 5.3%.

Diluted earnings per share came in at $0.14. Over the last 2 fiscal years, BLLN's revenue has grown at a 106.2% compound annual rate.

Summary generated from market data by MetaCap's automated system. Methodology

BillionToOne income statement (annual)

BillionToOne annual income statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31
Revenue305.11M152.58M71.73M
Revenue growth (YoY)+99.97%+112.72%—
Cost of Revenue96.65M71.67M54.42M
Gross Profit208.46M80.92M17.31M
Operating Expenses192.44M128.06M86.80M
Research & Development49.38M36.60M22.41M
Selling, General & Admin143.05M91.47M64.39M
Operating Income16.02M-47.15M-69.50M
Interest Expense95.00K2.39M3.27M
Other Income (Expense)-8.26M5.61M-13.18M
Pretax Income7.76M-41.54M-82.67M
Income Tax305.00K29.00K9.00K
Net Income7.45M-41.57M-82.68M
Net Income growth (YoY)———
EPS (Basic)0.18-4.12-8.45
EPS (Diluted)0.14-4.12-8.45
Shares Outstanding (Basic)15.88M10.08M9.78M
Shares Outstanding (Diluted)21.23M10.08M9.78M
EBITDA22.92M-40.15M-63.59M
Gross Margin68.32%53.03%24.13%
Operating Margin5.25%-30.90%-96.89%
Net Margin2.44%-27.24%-115.27%

This table shows 3 annual periods of BillionToOne's income statement, from FY 2025 back to FY 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow BLLN's reporting calendar. What is a income statement?

More financial data